Your browser doesn't support javascript.
loading
Factors associated with the uptake of biosimilars for breast cancer treatment from the perspectives of physicians and patients-Evidence from China.
Wu, Qiyou; Lian, Zhiwei; Wang, Xin; Cheng, Hanchao; Sun, Jing; Yu, Hui; Zhang, Gong; Wu, Fan; Liu, Jian; Chen, Chuanben.
Afiliación
  • Wu Q; School of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Lian Z; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Wang X; School of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Cheng H; School of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Sun J; School of Health Policy and Management, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Yu H; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Zhang G; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Wu F; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Liu J; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
  • Chen C; Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China.
Front Pharmacol ; 13: 1044798, 2022.
Article en En | MEDLINE | ID: mdl-36712662
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China